Literature DB >> 18942111

The Pax3-Cre transgene exhibits a rostrocaudal gradient of expression in the skeletal muscle lineage.

George Jarad, Jeffrey H Miner.   

Abstract

Pax3-Cre (P3Pro-Cre) transgenic mice have been used for conditional gene deletion and/or lineage tracing in derivatives of neural crest, neural tube, metanephric mesenchyme, and ureteric mesenchyme. However, the extent of its expression in skeletal muscle has not been reported. We investigated the expression of P3Pro-Cre in the skeletal muscle lineage using the R26R reporter and found an unexpected rostrocaudal gradient of expression. By X-gal staining, head, neck, forelimb, diaphragm, and most of the chest wall muscles did not show evidence of Cre expression, whereas all muscle groups posterior of the diaphragm stained blue. Intercostal muscles exhibited a rostrocaudal gradient of staining. The consistency of this expression pattern was demonstrated by using P3Pro-Cre to mutate a conditional dystroglycan allele. The result was loss of dystroglycan from caudal muscles, which exhibited the histological signs of muscle fiber injury and regeneration characteristic of muscular dystrophy. The lack of dystroglycan in regenerating myofibers suggests that the P3Pro-Cre transgene is active in satellite cells and/or in their precursors. In contrast, rostral muscles, including feeding and breathing muscles, maintained dystroglycan expression and were spared from disease. Accordingly, the mutants were viable for over a year. Its unique gradient of activity makes the P3Pro-Cre transgene a previously unappreciated yet powerful tool for manipulating gene expression in skeletal muscle and its precursors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18942111      PMCID: PMC2759890          DOI: 10.1002/dvg.20447

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  26 in total

1.  Neural crest expression of Cre recombinase directed by the proximal Pax3 promoter in transgenic mice.

Authors:  J Li; F Chen; J A Epstein
Journal:  Genesis       Date:  2000-02       Impact factor: 2.487

2.  Epitopes in the interacting regions of beta-dystroglycan (PPxY motif) and dystrophin (WW domain).

Authors:  A V Pereboev; N Ahmed; N thi Man; G E Morris
Journal:  Biochim Biophys Acta       Date:  2001-07-02

3.  Distinct cardiac malformations caused by absence of connexin 43 in the neural crest and in the non-crest neural tube.

Authors:  Shasha Liu; Fangyu Liu; Amanda E Schneider; Tara St Amand; Jonathan A Epstein; David E Gutstein
Journal:  Development       Date:  2006-04-19       Impact factor: 6.868

4.  Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses.

Authors:  P D Côté; H Moukhles; M Lindenbaum; S Carbonetto
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

Review 5.  Molecular basis of muscular dystrophies.

Authors:  R D Cohn; K P Campbell
Journal:  Muscle Nerve       Date:  2000-10       Impact factor: 3.217

6.  Role of fibroblast growth factor receptors 1 and 2 in the metanephric mesenchyme.

Authors:  Deepali Pitre Poladia; Kayle Kish; Benjamin Kutay; David Hains; Heather Kegg; Haotian Zhao; Carlton M Bates
Journal:  Dev Biol       Date:  2006-01-24       Impact factor: 3.582

7.  Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy.

Authors:  Steven A Moore; Fumiaki Saito; Jianguo Chen; Daniel E Michele; Michael D Henry; Albee Messing; Ronald D Cohn; Susan E Ross-Barta; Steve Westra; Roger A Williamson; Toshinori Hoshi; Kevin P Campbell
Journal:  Nature       Date:  2002-07-25       Impact factor: 49.962

Review 8.  Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models.

Authors:  Madeleine Durbeej; Kevin P Campbell
Journal:  Curr Opin Genet Dev       Date:  2002-06       Impact factor: 5.578

9.  Removal of dystroglycan causes severe muscular dystrophy in zebrafish embryos.

Authors:  Michael J Parsons; Isabel Campos; Elizabeth M A Hirst; Derek L Stemple
Journal:  Development       Date:  2002-07       Impact factor: 6.868

10.  Laminins promote postsynaptic maturation by an autocrine mechanism at the neuromuscular junction.

Authors:  Hiroshi Nishimune; Gregorio Valdez; George Jarad; Casey L Moulson; Ulrich Müller; Jeffrey H Miner; Joshua R Sanes
Journal:  J Cell Biol       Date:  2008-09-15       Impact factor: 10.539

View more
  13 in total

1.  Comparative proteomic profiling of dystroglycan-associated proteins in wild type, mdx, and Galgt2 transgenic mouse skeletal muscle.

Authors:  Jung Hae Yoon; Eric Johnson; Rui Xu; Laura T Martin; Paul T Martin; Federica Montanaro
Journal:  J Proteome Res       Date:  2012-07-30       Impact factor: 4.466

2.  Dystroglycan does not contribute significantly to kidney development or function, in health or after injury.

Authors:  George Jarad; Jeffrey W Pippin; Stuart J Shankland; Jordan A Kreidberg; Jeffrey H Miner
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-05

3.  Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.

Authors:  Rui Xu; Neha Singhal; Yelda Serinagaoglu; Kumaran Chandrasekharan; Mandar Joshi; John A Bauer; Paulus M L Janssen; Paul T Martin
Journal:  Am J Pathol       Date:  2015-10       Impact factor: 4.307

4.  FGF8 is essential for formation of the ductal system in the male reproductive tract.

Authors:  Jirouta Kitagaki; Yutaka Ueda; Xuan Chi; Nirmala Sharma; Cynthia M Elder; Erika Truffer; Frank Costantini; Mark Lewandoski; Alan O Perantoni
Journal:  Development       Date:  2011-12       Impact factor: 6.868

5.  Specific and spatial labeling of P0-Cre versus Wnt1-Cre in cranial neural crest in early mouse embryos.

Authors:  Guiqian Chen; Mohamed Ishan; Jingwen Yang; Satoshi Kishigami; Tomokazu Fukuda; Greg Scott; Manas K Ray; Chenming Sun; Shi-You Chen; Yoshihiro Komatsu; Yuji Mishina; Hong-Xiang Liu
Journal:  Genesis       Date:  2017-04-18       Impact factor: 2.487

6.  B4GALNT2 (GALGT2) Gene Therapy Reduces Skeletal Muscle Pathology in the FKRP P448L Mouse Model of Limb Girdle Muscular Dystrophy 2I.

Authors:  Paul J Thomas; Rui Xu; Paul T Martin
Journal:  Am J Pathol       Date:  2016-09       Impact factor: 4.307

7.  Geminin loss causes neural tube defects through disrupted progenitor specification and neuronal differentiation.

Authors:  Ethan S Patterson; Laura E Waller; Kristen L Kroll
Journal:  Dev Biol       Date:  2014-07-01       Impact factor: 3.582

8.  Distinct contributions of Galgt1 and Galgt2 to carbohydrate expression and function at the mouse neuromuscular junction.

Authors:  Neha Singhal; Rui Xu; Paul T Martin
Journal:  Mol Cell Neurosci       Date:  2012-09-07       Impact factor: 4.314

9.  UTX-guided neural crest function underlies craniofacial features of Kabuki syndrome.

Authors:  Karl B Shpargel; Joshua Starmer; Chaochen Wang; Kai Ge; Terry Magnuson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-09       Impact factor: 11.205

10.  Scaffolding proteins DLG1 and CASK cooperate to maintain the nephron progenitor population during kidney development.

Authors:  Sun-Young Ahn; Yeawon Kim; Sung Tae Kim; Wojciech Swat; Jeffrey H Miner
Journal:  J Am Soc Nephrol       Date:  2013-05-09       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.